Warhound Launches With $200M to Deploy Genetically Engineered K9s Equipped With High-Tech Gear
A stealth startup co-founded by Ben Lamm and Palmer Luckey has emerged with a $1.2 billion valuation to solve the U.S. military’s dwindling supply of working dogs.
By Julia Novak ·
Warhound, a startup that had operated in stealth until today, officially unveiled its mission to genetically engineer war dogs for the U.S. military and law enforcement. The company, which emerged from the shadows on Thursday, is backed by a massive $200 million funding round. Investors in the round include major names such as Sequoia, 8VC, Corner Ventures, and In-Q-Tel, the latter being a venture firm supported by the CIA and other U.S. intelligence agencies. This significant capital injection values Warhound at $1.2 billion.
The financial scale of the launch reflects the urgency of the problem Warhound aims to solve. According to data cited in the company’s launch announcement, over 80% of the working dogs currently serving in the U.S. military are imported from Europe. Furthermore, fewer than half of these foreign-sourced animals are deemed fit for service. This reliance on foreign supplies has led to a shrinking domestic stock of capable K9s, prompting the need for a new, engineered solution.
The venture is a collaboration between Ben Lamm of Colossal Biosciences and Palmer Luckey of Anduril. Lamm revealed that he first met Luckey approximately a year ago at a conference, where Luckey expressed concern about the state of military working dogs. Following their meeting, Lamm began researching the breeding practices of working dogs, discovering that many fail training due to inherited issues such as poor eyesight, cancer, hip dysplasia, or muscle atrophy. Lamm believed that genetic engineering could enhance these animals for health, longevity, speed, agility, and even superior olfactory capabilities for bomb detection.
The technical approach involves studying top-performing breeds, specifically the Belgian Malinois and German Shepherd. The team has collected cell lines from these animals and placed them in a biobank. Using this genetic material, Warhound plans to edit the dogs’ DNA by adding genes that improve performance and removing those that hinder it. The goal is to create a new type of dog with characteristics specifically suited for demanding missions. The first batch of these dogs is scheduled to be cloned and incubated soon, with births expected in early 2027 and service beginning within two years.
While Colossal provides the genetic engineering technology, Anduril will supply the hardware and software necessary for the dogs’ operations. This includes equipment such as protection vests and goggles designed to assist both the dogs and their handlers with situational awareness. Lamm described the concept as adding technology "on top of the dog, not in the dog," such as bulletproof vests with data sensors that transmit information to handlers. This integration aims to make the dogs safer and healthier, ultimately improving their performance in the line of duty and protecting their human partners.
The business structure involves Colossal owning equity in Warhound and licensing its technology, while Luckey serves as a partner without holding equity. Viagen, another company owned by Colossal, will partner with Warhound to handle the cloning process, leveraging its high success rate in cloning technology. The company expects to sell these engineered dogs to first responders, the Department of Defense, military service groups, and police forces, though pricing has not yet been determined.
To address concerns about civilian safety and animal welfare, Warhound stated that each dog will be trained like any standard military working dog and managed by the purchasing entity. The company is working under the guidance of the American Humane Society to certify its training program. Additionally, there is a plan for retired dogs to enter the Society’s Military Working Dog Reunification Program or other support programs. The American Humane Society applauded the collaboration, stating they look forward to ensuring the animals are treated humanely.
Lamm noted that the company has already briefed numerous government groups on the business model. The initiative represents a significant shift in how the U.S. approaches its canine workforce, moving from traditional breeding and importation to a model of genetic optimization and technological augmentation.
